recurrent squamous cell lung carcinoma

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 Trial in Canada, United States

Active, not recruiting
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
  • Ipilimumab
  • +4 more
  • Birmingham, Alabama
  • +1206 more
May 6, 2022

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 Trial in United States (drug, biological,

Completed
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
  • Birmingham, Alabama
  • +992 more
Dec 1, 2021

Treating Recurrent Stage IV Squamous Cell Lung Cancer

Active, not recruiting
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
  • Birmingham, Alabama
  • +1003 more
Nov 29, 2021

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

Completed
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC V7
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021

ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation Trial in Canada, United States (Laboratory Biomarker Analysis,

Completed
  • ATM Gene Mutation
  • +20 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +1156 more
Jun 22, 2021

CCND1 Gene Amplification, CCND2 Gene Amplification, CCND3 Gene Amplification Trial in United States (Docetaxel, Laboratory

Completed
  • CCND1 Gene Amplification
  • +5 more
  • Birmingham, Alabama
  • +1064 more
May 25, 2021

FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR2 Gene Amplification Trial in Canada, United States (Docetaxel, FGFR

Completed
  • FGFR1 Gene Amplification
  • +7 more
  • Birmingham, Alabama
  • +1083 more
May 25, 2021

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma Trial in Canada, United States (Laboratory

Completed
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma
  • Birmingham, Alabama
  • +1110 more
Sep 29, 2020

MET Positive, Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 Trial in United States

Terminated
  • MET Positive
  • +2 more
  • Erlotinib Hydrochloride
  • +2 more
  • Jonesboro, Arkansas
  • +626 more
Mar 17, 2020

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma Trial (Docetaxel, Laboratory Biomarker Analysis,

Withdrawn
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma
  • (no location specified)
Oct 28, 2015